MAP2K7 and malignant peripheral nerve sheath tumor: However, the efficacy of MEKi monotherapy was relatively limited in MPNSTs and the underlying mechanisms remain largely unexplored, which hinders the implications of MEK inhibitors (MEKis) in MPNST therapy.